Correction of Hyponatremia May Be a Treatment Stratification Biomarker: A Two-Stage Systematic Review and Meta-Analysis

Correction of Hyponatremia May Be a Treatment Stratification Biomarker: A Two-Stage Systematic Review and Meta-Analysis

Changes in serum sodium concentration ([Na+]serum) can permit evaluation of the treatment effect of vasopressin antagonists (vaptans) in patients with worsening heart failure (HF) or cirrhotic ascites; that is, they may act as a treatment stratification biomarker. A two-stage systematic review and m...

Full description

Bibliographic Details
Main Authors: Francisco Herrera-Gómez, Diana Monge-Donaire, Carlos Ochoa-Sangrador, Juan Bustamante-Munguira, Eric Alamartine, F. Javier Álvarez
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Journal of Clinical Medicine
Subjects:
hyponatremia
biomarkers
drug evaluation
heart failure
ascites
Online Access:http://www.mdpi.com/2077-0383/7/9/262

Internet

http://www.mdpi.com/2077-0383/7/9/262

Similar Items